| Particulars |
|
|
|
| Company Name
| Sanofi India Ltd
| Year End
| 202412
|
| Full Year |
| Equity (₹ Cr.) |
23.03 |
B.V. (₹) |
373.70 |
| Sales(₹ Cr.) |
2,013.20 |
NP (₹ Cr.) |
362.39 |
| NP Var% |
-39.00 |
Div% |
1,170.00 |
| CPS(₹) |
173.30 |
EPS (₹) |
157.40 |
| Traded Value(₹ Lakhs) |
47.33 |
52 Week High |
10,526.00 |
| 52 Week Low |
4,146.00 |
Price BSE |
6,050.00 |
| Price NSE |
6,039.00 |
Market Capital (₹ Cr.) |
13,932.23 |
| P/C Ratio |
34.90 |
P/E Ratio |
38.40 |
| Price Vs.BV |
16.19 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
514.90 |
| NP(₹ Cr.) |
85.32 |
NP Var % |
22.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
2,192.20 |
| OPM |
20.62 |
NP |
421.55 |
| NP Var% |
-38.63 |
EPS |
157.36 |
| PE |
38.44 |
|
|